Amritanjali Ayurved Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-12-2024
- Paid Up Capital ₹ 0.10 M
as on 06-12-2024
- Company Age 8 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 0.07%
(FY 2023)
- Profit 14.68%
(FY 2023)
- Ebitda 1261.92%
(FY 2023)
- Net Worth 18.15%
(FY 2023)
- Total Assets -24.40%
(FY 2023)
About Amritanjali Ayurved
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sanjay Silavat and Saroj Patidar serve as directors at the Company.
- CIN/LLPIN
U74999RJ2016PTC055895
- Company No.
055895
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Sep 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Udaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Amritanjali Ayurved Private Limited offer?
Amritanjali Ayurved Private Limited offers a wide range of products and services, including Ayurvedic Powder and Medicinal Herbs, Herbs,Sticks and Roots, Medicinal Roots, Herbal Powder, Fresh Flowers, Plants & Trees, Outdoor Plant, Cooking Spices and Masala, Seed Spices, Fruit Plants, Ayurvedic,Herbal Products & Medicine.
Who are the key members and board of directors at Amritanjali Ayurved?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Silavat  | Director | 07-Jun-2022 | Current |
| Saroj Patidar | Director | 07-Jun-2022 | Current |
Financial Performance of Amritanjali Ayurved.
Amritanjali Ayurved Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.07% increase. The company also saw a substantial improvement in profitability, with a 14.68% increase in profit. The company's net worth Soared by an impressive increase of 18.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amritanjali Ayurved?
Unlock access to Amritanjali Ayurved's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Amritanjali Ayurved?
Unlock and access historical data on people associated with Amritanjali Ayurved, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amritanjali Ayurved, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amritanjali Ayurved's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
